Conclusion
Quality risk management for manufacturing of pharmaceutical products - Concept and regulations
Article REF: PHA3050 V1
Conclusion
Quality risk management for manufacturing of pharmaceutical products - Concept and regulations

Authors : Mélisande BERNARD, Hassane SADOU YAYE, Jean-Jacques HOURI, Bernard DO

Publication date: December 10, 2015 | Lire en français

Logo Techniques de l'Ingenieur You do not have access to this resource.
Request your free trial access! Free trial

Already subscribed?

5. Conclusion

Risk management is a process underpinned by a set of principles, supported by a structure appropriate to the organization and its external environment. The effective implementation of risk management must be proportionate to the level of risk, coordinated with the company's other activities, comprehensive in scope, integrated into routine activities and dynamic yet sensitive to changing circumstances.

The pharmaceutical industry, subject to precise regulatory conditions guaranteeing the safety of medicines, must set up an efficient and precise quality management system to guarantee control of each of its activities.

ICH Q8, Q9 and Q10 represent the pharmaceutical industry's essential recommendations, based on a solid scientific foundation, risk management and quality management. ICH Q9 is the standard for risk management. This text has been...

You do not have access to this resource.
Logo Techniques de l'Ingenieur

Exclusive to subscribers. 97% yet to be discovered!

You do not have access to this resource. Click here to request your free trial access!

Already subscribed?


Article included in this offer

"Drugs and pharmaceuticals"

( 125 articles )

Complete knowledge base

Updated and enriched with articles validated by our scientific committees

Services

A set of exclusive tools to complement the resources

View offer details
Contact us